PLK1 and neoplasm: Since two distinct EBNA2 mutants that both target independent PLK1‐related functions of the EBNA2/PLK1 complex promote cancerogenesis, we conclude that PLK1 might act as a tumor suppressor in EBNA2‐driven lymphomagenesis.